After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...